Literature DB >> 23382360

Gastrointestinal motility disorder assessment in systemic sclerosis.

Edoardo Savarino1, Federico Mei, Andrea Parodi, Massimo Ghio, Manuele Furnari, Adelina Gentile, Michela Berdini, Antonio Di Sario, Emanuele Bendia, Patrizia Bonazzi, Emidio Scarpellini, Lucrezia Laterza, Vincenzo Savarino, Antonio Gasbarrini.   

Abstract

OBJECTIVES: SSc is a clinically heterogeneous and generalized disease, characterized by thickness of the connective tissue of the skin and internal organs, such as the digestive tract, impairing gastrointestinal (GI) motility. Our aim is to evaluate retrospectively abnormalities of oesophageal motility, gastric emptying, oro-cecal transit time (OCTT) and small intestine bacterial overgrowth (SIBO) in a large cohort of SSc patients.
METHODS: Ninety-nine SSc patients were included in the study. Forty-two patients underwent oesophageal conventional manometry, 45 performed a [(13)C]octanoic acid breath test to measure gastric emptying time and all 99 patients performed a lactulose breath test in order to evaluate OCTT and SIBO. Data were compared with healthy controls.
RESULTS: In SSc patients, median lower oesophageal sphincter (LOS) pressure [14 mmHg (25th-75th; 8-19) vs 24 mmHg (19-28); P < 0.01] and median wave amplitude [30 mmHg (16-70) vs 72 mmHg (48-96); P < 0.01] were lower than in controls. Oesophageal involvement, defined as reduced LOS pressure and ineffective oesophageal motility pattern, was encountered in 70% of SSc patients. A delayed gastric emptying time was present in 38% of SSc patients: mean t½ was 141 ± 79 min vs 90 ± 40 min of controls (P < 0.01). Also, OCTT was significantly delayed in SSc: median OCTT was 160 min (25th-75th; 135-180) vs 105 min (25th-75th; 90-135) of controls (P < 0.01). SIBO was observed in 46% of SSc compared with 5% of controls (P < 0.01).
CONCLUSION: GI involvement is very frequent in SSc patients. Oesophagus and small bowel are more frequently impaired, whereas delayed gastric emptying is less common.

Entities:  

Keywords:  13C-octanoate breath test; gastrointestinal motility; lactulose breath test; oesophageal manometry; scleroderma; systemic sclerosis

Mesh:

Year:  2013        PMID: 23382360     DOI: 10.1093/rheumatology/kes429

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  21 in total

1.  Technical feasibility of real-time elastography to assess the peri-oral region in patients affected by systemic sclerosis.

Authors:  Paola Maria Cannaò; Valeriano Vinci; Fabio Caviggioli; Marco Klinger; Davide Orlandi; Francesco Sardanelli; Giovanni Serafini; Luca Maria Sconfienza
Journal:  J Ultrasound       Date:  2014-07-29

2.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

Review 3.  Early systemic sclerosis-opportunities for treatment.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Christina Katsiari; Dimitrios Bogdanos; Ian C Chikanza
Journal:  Clin Rheumatol       Date:  2015-02-26       Impact factor: 2.980

Review 4.  Will MRI of gastrointestinal function parallel the clinical success of cine cardiac MRI?

Authors:  Caroline Hoad; Christopher Clarke; Luca Marciani; Martin John Graves; Maura Corsetti
Journal:  Br J Radiol       Date:  2018-10-24       Impact factor: 3.039

Review 5.  Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.

Authors:  S Kumar; J Singh; S Rattan; A J DiMarino; S Cohen; S A Jimenez
Journal:  Aliment Pharmacol Ther       Date:  2017-02-09       Impact factor: 8.171

6.  Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG.

Authors:  Sumit Kumar; Jagmohan Singh; Ramalinga Kedika; Fabian Mendoza; Sergio A Jimenez; Erik S Blomain; Anthony J DiMarino; Sidney Cohen; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-12       Impact factor: 4.052

7.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

Review 8.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

9.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

Review 10.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.